Sinalização PI3K/Akt/mTOR
Os inibidores da sinalização PI3K/Akt/mTOR são compostos que têm como alvo as vias da fosfoinositídeo 3-quinase (PI3K), da quinase Akt e do alvo da rapamicina em mamíferos (mTOR). Essas vias são reguladores críticos do crescimento celular, sobrevivência, metabolismo e autofagia, tornando-os alvos-chave na pesquisa de câncer e distúrbios metabólicos. A inibição dessas vias pode ajudar a controlar o crescimento e a proliferação tumoral, oferecendo estratégias terapêuticas potenciais para vários tipos de câncer e outras doenças caracterizadas por sinalização celular desregulada. Na CymitQuimica, oferecemos uma ampla seleção de inibidores de alta qualidade de PI3K/Akt/mTOR para apoiar sua pesquisa em oncologia, sinalização celular e doenças metabólicas.
Subcategorias de "Sinalização PI3K/Akt/mTOR"
Exibir 2 mais subcategorias
Produtos da "Sinalização PI3K/Akt/mTOR"
Ordenar por
TCS 21311
CAS:TCS 21311 (NIBR3049) selectively inhibits JAK3 (IC50: 8 nM) and PKCα/θ & GSK3β; >100x selective over JAK1, JAK2, TYK2.Fórmula:C27H25F3N4O4Pureza:≥98%Cor e Forma:SolidPeso molecular:526.51(Rac)-BRD0705
CAS:(Rac)-BRD0705 is a less active racemate of BRD0705. BRD0705 is an effective and selective inhibitor of GSK3α.Fórmula:C20H23N3OPureza:99.67%Cor e Forma:SolidPeso molecular:321.42Ref: TM-T12664
1mg96,00€5mg212,00€10mg316,00€25mg510,00€50mg695,00€100mg940,00€1mL*10mM (DMSO)155,00€GSK2636771
CAS:GSK2636771, an effective, specific, orally bioavailable, PI3Kβ inhibitor, has been used in cancer, lymphoma, solid neoplasm, recurrent solid neoplasm, andFórmula:C22H22F3N3O3Pureza:98.58% - ≥95%Cor e Forma:SolidPeso molecular:433.42Ref: TM-T2073
1mg43,00€2mg57,00€5mg88,00€10mg150,00€25mg254,00€50mg359,00€100mg547,00€1mL*10mM (DMSO)88,00€Modotuximab
CAS:Modotuximab (DS 1024) is a humanized antibody targeting EGFR with antitumor activity that accelerates the internalization and degradation of EGFR.Pureza:95% - 95%Cor e Forma:LiquidEGFRVIII Protein, Human, Recombinant (His & Avi), FITC-Labeled
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification.Cor e Forma:Lyophilized PowderPeso molecular:41.6 kDa (predicted). Due to glycosylation, the protein migrates to 68-80 kDa based on Tris-Bis PAGE result.SB 216763
CAS:SB 216763 (SB216763) is an effective and specific GSK-3α/β inhibitor (IC50: 34.3 nM).Fórmula:C19H12Cl2N2O2Pureza:99.13% - 99.61%Cor e Forma:SolidPeso molecular:371.22Ref: TM-T3077
2mg39,00€5mg52,00€10mg79,00€25mg131,00€50mg197,00€100mg334,00€500mg803,00€1mL*10mM (DMSO)52,00€GSK2292767 FA
GSK2292767 FA: potent PI3Kδ inhibitor, pIC50=10.1, 500x selectivity, for respiratory research.Fórmula:C25H30N6O7SPureza:99.21%Cor e Forma:SoildPeso molecular:558.61PI3Kδ-IN-17
CAS:PI3Kδ-IN-17 (Compound S5) is a potent PI3K δ inhibitor, exhibiting an IC50 value of 2.82 nM and demonstrates significant efficacy in suppressing theFórmula:C23H24F3N7O2Pureza:98%Cor e Forma:SolidPeso molecular:487.48PD153035 hydrochloride
CAS:PD153035 hydrochloride (ZM 252868) is a effective and selective inhibitor of EGFR; few influence against FGFR, PGDFR, InsR, CSF-1, and Src.Fórmula:C16H15BrClN3O2Pureza:99.39% - ≥95%Cor e Forma:SolidPeso molecular:396.67GSK3-IN-2
CAS:GSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.Fórmula:C17H19N3OSPureza:98.8%Cor e Forma:SolidPeso molecular:313.42DS-7423
CAS:DS-7423: a dual PI3K/mTOR inhibitor; IC50s-PI3Kα: 15.6 nM, mTOR: 34.9 nM, PI3Kβ: 1,143 nM, PI3Kγ: 249 nM, PI3Kδ: 262 nM.Fórmula:C22H27F3N10O2Pureza:99.68%Cor e Forma:SolidPeso molecular:520.51Ref: TM-T36083
1mg127,00€5mg283,00€10mg432,00€25mg707,00€50mg938,00€100mg1.378,00€1mL*10mM (DMSO)321,00€Cbz-B3A
CAS:Cbz-B3A is a potent inhibitor of mTORC1 signalling, inhibits phosphorylation of eIF4E-binding protein 1 (4EBP1) and blocks translation by 68%.Fórmula:C35H58N6O9Pureza:98.63%Cor e Forma:SolidPeso molecular:706.87AZ7550 hydrochloride
CAS:AZ7550 hydrochloride (AZ7550 hydrochloride ), an active metabolite of AZD9291, inhibits the activity of IGF1R (IC50: 1.6 μM).Fórmula:C27H32ClN7O2Pureza:97.07%Cor e Forma:SolidPeso molecular:522.04AMPK activator 4
CAS:Potent, selective AMPK activator 4 enhances glucose tolerance and insulin sensitivity without affecting mitochondrial complex I.Fórmula:C24H21ClN2O3Pureza:100% - 99.75%Cor e Forma:SolidPeso molecular:420.89Ref: TM-T62238
1mg90,00€5mg183,00€10mg354,00€25mg595,00€50mg847,00€100mg1.159,00€500mg2.308,00€1mL*10mM (DMSO)215,00€BEBT-908
CAS:BEBT-908 (PI3Kα inhibitor 1) is a selective PI3Kα inhibitor (IC50 <0.1 μM). BEBT-908 also inhibits HDAC (0.1 μM≤IC50≤1 μM).Fórmula:C23H25N9O3SPureza:98.96%Cor e Forma:SolidPeso molecular:507.57Ref: TM-T16529
1mg120,00€2mg167,00€5mg250,00€10mg378,00€25mg630,00€50mg898,00€100mg1.216,00€500mg2.442,00€1mL*10mM (DMSO)279,00€EGFRVIII Protein, Human, Recombinant (His & Avi), Biotinylated
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification.Cor e Forma:Lyophilized PowderPeso molecular:41.6 kDa (predicted). Due to glycosylation, the protein migrates to 60-78 kDa based on Tris-Bis PAGE result.M77976
CAS:M77976 inhibits PDK4 with an IC50 of 648 μM, targeting obesity and diabetes research.Fórmula:C17H16N2O3Pureza:99.80%Cor e Forma:SolidPeso molecular:296.32Serclutamab
CAS:Serclutamab, a humanized chimeric monoclonal antibody of the IgG1-κ isotype, selectively targets the epidermal growth factor receptor (EGFR).Pureza:98%Cor e Forma:LiquidPS10
CAS:PS10 is a broad-spectrum PDK inhibitor that inhibits PDK2 and significantly increases the activity of the pyruvate dehydrogenase complex.Fórmula:C14H13NO6SPureza:99.01%Cor e Forma:SolidPeso molecular:323.32Anti-Phospho-EGFR (Tyr1068) Antibody (3Q245)
Anti-Phospho-EGFR (Tyr1068) Antibody (3Q245) is an antibody targeting Phospho-EGFR (Tyr1068). Anti-Phospho-EGFR (Tyr1068) Antibody (3Q245) can be used in ELISA, WB.Cor e Forma:Odour Liquid
